{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:35:29Z","timestamp":1791311729606,"version":"4.3.1"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T00:00:00Z","timestamp":1239062400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Imaging and Behavior"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s11682-009-9067-2","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T14:16:00Z","timestamp":1239027360000},"page":"246-261","source":"Crossref","is-referenced-by-count":28,"title":["Amyloid Imaging in Alzheimer\u2019s Disease and Other Dementias"],"prefix":"10.1007","volume":"3","author":[{"given":"Michelle T.","family":"Fodero-Tavoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cappai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona A.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerryn E.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Adlard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Cowie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,7]]},"reference":[{"issue":"3","key":"9067_CR1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0306-4522(02)00907-7","volume":"117","author":"ED Agdeppa","year":"2003","unstructured":"Agdeppa, E. D., Kepe, V., Petri, A., Satyamurthy, N., Liu, J., Huang, S. C., et al. (2003). In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18) F]fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene) malononitrile. Neuroscience, 117(3), 723\u2013730. doi: 10.1016\/S0306-4522(02)00907-7 .","journal-title":"Neuroscience"},{"issue":"11","key":"9067_CR2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","volume":"65","author":"HJ Aizenstein","year":"2008","unstructured":"Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., et al. (2008). Frequent amyloid deposition without significant cognitive impairment among the elderly. Archives of Neurology, 65(11), 1509\u20131517. doi: 10.1001\/archneur.65.11.1509 .","journal-title":"Archives of Neurology"},{"issue":"1","key":"9067_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.20889","volume":"60","author":"HA Archer","year":"2006","unstructured":"Archer, H. A., Edison, P., Brooks, D. J., Barnes, J., Frost, C., Yeatman, T., et al. (2006). Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study. Annals of Neurology, 60(1), 145\u2013147. doi: 10.1002\/ana.20889 .","journal-title":"Annals of Neurology"},{"issue":"6","key":"9067_CR4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0197-4580(00)00173-1","volume":"21","author":"SE Arnold","year":"2000","unstructured":"Arnold, S. E., Han, L. Y., Clark, C. M., Grossman, M., & Trojanowski, J. Q. (2000). Quantitative neurohistological features of frontotemporal degeneration. Neurobiology of Aging, 21(6), 913\u2013919. doi: 10.1016\/S0197-4580(00)00173-1 .","journal-title":"Neurobiology of Aging"},{"issue":"3 Pt 1","key":"9067_CR5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology, 42(3 Pt 1), 631\u2013639.","journal-title":"Neurology"},{"issue":"4","key":"9067_CR6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1037\/0894-4105.19.4.520","volume":"19","author":"L Backman","year":"2005","unstructured":"Backman, L., Jones, S., Berger, A. K., Laukka, E. J., & Small, B. J. (2005). Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology, 19(4), 520\u2013531. doi: 10.1037\/0894-4105.19.4.520 .","journal-title":"Neuropsychology"},{"issue":"21","key":"9067_CR7","doi-asserted-by":"crossref","first-page":"12462","DOI":"10.1073\/pnas.2034101100","volume":"100","author":"BJ Bacskai","year":"2003","unstructured":"Bacskai, B. J., Hickey, G. A., Skoch, J., Kajdasz, S. T., Wang, Y., Huang, G. F., et al. (2003). Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 100(21), 12462\u201312467. doi: 10.1073\/pnas.2034101100 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"9067_CR8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.64.3.431","volume":"64","author":"BJ Bacskai","year":"2007","unstructured":"Bacskai, B. J., Frosch, M. P., Freeman, S. H., Raymond, S. B., Augustinack, J. C., Johnson, K. A., et al. (2007). Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Archives of Neurology, 64(3), 431\u2013434. doi: 10.1001\/archneur.64.3.431 .","journal-title":"Archives of Neurology"},{"key":"9067_CR9","first-page":"S194","volume":"42","author":"JR Barrio","year":"1999","unstructured":"Barrio, J. R., Huang, S. C., Cole, G., Satyamurthy, N., Petric, A., Phelps, M. E., et al. (1999). PET imaging of tangles and plaques in Alzheimer disease with a highly lipophilic probe. Journal of Labelled Compounds & Radiopharmaceuticals, 42, S194\u2013S195.","journal-title":"Journal of Labelled Compounds & Radiopharmaceuticals"},{"issue":"10","key":"9067_CR10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0011-5029(00)90028-2","volume":"46","author":"DA Bennett","year":"2000","unstructured":"Bennett, D. A. (2000). Part I. Epidemiology and public health impact of Alzheimer's disease. Disease-a-month, 46(10), 657\u2013665. doi: 10.1016\/S0011-5029(00)90028-2 .","journal-title":"Disease-a-month"},{"issue":"12","key":"9067_CR11","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., et al. (2006). Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology, 66(12), 1837\u20131844. doi: 10.1212\/01.wnl.0000219668.47116.e6 .","journal-title":"Neurology"},{"issue":"3","key":"9067_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1212\/01.wnl.0000265815.38958.b6","volume":"69","author":"AL Boxer","year":"2007","unstructured":"Boxer, A. L., Rabinovici, G. D., Kepe, V., Goldman, J., Furst, A. J., Huang, S. C., et al. (2007). Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease. Neurology, 69(3), 283\u2013290. doi: 10.1212\/01.wnl.0000265815.38958.b6 .","journal-title":"Neurology"},{"issue":"4","key":"9067_CR13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak, H., & Braak, E. (1997). Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiology of Aging, 18(4), 351\u2013357. doi: 10.1016\/S0197-4580(97)00056-0 .","journal-title":"Neurobiology of Aging"},{"issue":"34","key":"9067_CR14","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., et al. (2005). Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. Journal of Neuroscience, 25(34), 7709\u20137717. doi: 10.1523\/JNEUROSCI.2177-05.2005 .","journal-title":"Journal of Neuroscience"},{"key":"9067_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1440.011","volume":"1124","author":"RL Buckner","year":"2008","unstructured":"Buckner, R. L., Andrews-Hanna, J. R., & Schacter, D. L. (2008). The brain's default network: anatomy, function, and relevance to disease. Annals of the New York Academy of Sciences, 1124, 1\u201338. doi: 10.1196\/annals.1440.011 .","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"9067_CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2353\/ajpath.2007.070182","volume":"171","author":"NJ Cairns","year":"2007","unstructured":"Cairns, N. J., Neumann, M., Bigio, E. H., Holm, I. E., Troost, D., Hatanpaa, K. J., et al. (2007). TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. American Journal of Pathology, 171(1), 227\u2013240. doi: 10.2353\/ajpath.2007.070182 .","journal-title":"American Journal of Pathology"},{"issue":"9","key":"9067_CR17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1357-2725(99)00027-8","volume":"31","author":"R Cappai","year":"1999","unstructured":"Cappai, R., & White, A. R. (1999). Amyloid beta. The International Journal of Biochemistry & Cell Biology, 31(9), 885\u2013889. doi: 10.1016\/S1357-2725(99)00027-8 .","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"3","key":"9067_CR18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.media.2007.02.002","volume":"11","author":"YC Chou","year":"2007","unstructured":"Chou, Y. C., Teng, M. M., Guo, W. Y., Hsieh, J. C., & Wu, Y. T. (2007). Classification of hemodynamics from dynamic-susceptibility-contrast magnetic resonance (DSC-MR) brain images using noiseless independent factor analysis. Medical Image Analysis, 11(3), 242\u2013253. doi: 10.1016\/j.media.2007.02.002 .","journal-title":"Medical Image Analysis"},{"issue":"1","key":"9067_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000109754","volume":"16","author":"CM Clark","year":"2008","unstructured":"Clark, C. M., Davatzikos, C., Borthakur, A., Newberg, A., Leight, S., Lee, V. M., et al. (2008). Biomarkers for early detection of Alzheimer pathology. Neuro-Signals, 16(1), 11\u201318. doi: 10.1159\/000109754 .","journal-title":"Neuro-Signals"},{"issue":"11","key":"9067_CR20","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/WNL.38.11.1688","volume":"38","author":"L Davies","year":"1988","unstructured":"Davies, L., Wolska, B., Hilbich, C., Multhaup, G., Martins, R., Simms, G., et al. (1988). A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology, 38(11), 1688\u20131693.","journal-title":"Neurology"},{"issue":"Suppl 1","key":"9067_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S1041610297004900","volume":"9","author":"MJ Leon de","year":"1997","unstructured":"de Leon, M. J., Convit, A., DeSanti, S., Bobinski, M., George, A. E., Wisniewski, H. M., et al. (1997). Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease. International Psychogeriatrics, 9(Suppl 1), 183\u2013190. doi: 10.1017\/S1041610297004900 . discussion 247-152.","journal-title":"International Psychogeriatrics"},{"issue":"22","key":"9067_CR22","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1523\/JNEUROSCI.1189-06.2006","volume":"26","author":"A Deshpande","year":"2006","unstructured":"Deshpande, A., Mina, E., Glabe, C., & Busciglio, J. (2006). Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. Journal of Neuroscience, 26(22), 6011\u20136018. doi: 10.1523\/JNEUROSCI.1189-06.2006 .","journal-title":"Journal of Neuroscience"},{"issue":"5","key":"9067_CR23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0197-4580(01)00271-8","volume":"22","author":"BC Dickerson","year":"2001","unstructured":"Dickerson, B. C., Goncharova, I., Sullivan, M. P., Forchetti, C., Wilson, R. S., Bennett, D. A., et al. (2001). MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiology of Aging, 22(5), 747\u2013754. doi: 10.1016\/S0197-4580(01)00271-8 .","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"9067_CR24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuroimage.2007.09.020","volume":"39","author":"A Drzezga","year":"2008","unstructured":"Drzezga, A., Grimmer, T., Henriksen, G., Stangier, I., Perneczky, R., Diehl-Schmid, J., et al. (2008). Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. NeuroImage, 39(2), 619\u2013633. doi: 10.1016\/j.neuroimage.2007.09.020 .","journal-title":"NeuroImage"},{"issue":"8","key":"9067_CR25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois, B., Feldman, H. H., Jacova, C., Dekosky, S. T., Barberger-Gateau, P., Cummings, J., et al. (2007). Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. The Lancet Neurology, 6(8), 734\u2013746. doi: 10.1016\/S1474-4422(07)70178-3 .","journal-title":"The Lancet Neurology"},{"issue":"8","key":"9067_CR26","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0006-2952(03)00534-3","volume":"66","author":"A Eckert","year":"2003","unstructured":"Eckert, A., Keil, U., Marques, C. A., Bonert, A., Frey, C., Schussel, K., et al. (2003). Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochemical Pharmacology, 66(8), 1627\u20131634. doi: 10.1016\/S0006-2952(03)00534-3 .","journal-title":"Biochemical Pharmacology"},{"issue":"7","key":"9067_CR27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","volume":"68","author":"P Edison","year":"2007","unstructured":"Edison, P., Archer, H. A., Hinz, R., Hammers, A., Pavese, N., Tai, Y. F., et al. (2007). Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology, 68(7), 501\u2013508. doi: 10.1212\/01.wnl.0000244749.20056.d4 .","journal-title":"Neurology"},{"issue":"12","key":"9067_CR28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","volume":"79","author":"P Edison","year":"2008","unstructured":"Edison, P., Rowe, C. C., Rinne, J. O., Ng, S., Ahmed, I., Kemppainen, N., et al. (2008). Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. Journal of Neurology, Neurosurgery and Psychiatry, 79(12), 1331\u20131338. doi: 10.1136\/jnnp.2007.127878 .","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"Pt 11","key":"9067_CR29","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","volume":"129","author":"H Engler","year":"2006","unstructured":"Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., et al. (2006). Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain, 129(Pt 11), 2856\u20132866. doi: 10.1093\/brain\/awl178 .","journal-title":"Brain"},{"issue":"1","key":"9067_CR30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00259-007-0523-1","volume":"35","author":"H Engler","year":"2008","unstructured":"Engler, H., Santillo, A. F., Wang, S. X., Lindau, M., Savitcheva, I., Nordberg, A., et al. (2008). In vivo amyloid imaging with PET in frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging, 35(1), 100\u2013106. doi: 10.1007\/s00259-007-0523-1 .","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"3","key":"9067_CR31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S. Y., Dence, C. S., Shah, A. R., et al. (2006). Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta(42) in humans. Annals of Neurology, 59(3), 512\u2013519. doi: 10.1002\/ana.20730 .","journal-title":"Annals of Neurology"},{"issue":"3","key":"9067_CR32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","volume":"64","author":"AM Fagan","year":"2007","unstructured":"Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007). Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Archives of Neurology, 64(3), 343\u2013349. doi: 10.1001\/archneur.64.3.noc60123 .","journal-title":"Archives of Neurology"},{"issue":"39","key":"9067_CR33","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1523\/JNEUROSCI.0630-07.2007","volume":"27","author":"MT Fodero-Tavoletti","year":"2007","unstructured":"Fodero-Tavoletti, M. T., Smith, D. P., McLean, C. A., Adlard, P. A., Barnham, K. J., Foster, L. E., et al. (2007). In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. Journal of Neuroscience, 27(39), 10365\u201310371. doi: 10.1523\/JNEUROSCI.0630-07.2007 .","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"9067_CR34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2967\/jnumed.108.057984","volume":"50","author":"MT Fodero-Tavoletti","year":"2009","unstructured":"Fodero-Tavoletti, M. T., Rowe, C. C., McLean, C. A., Leone, L., Li, Q. X., Masters, C. L., et al. (2009). Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias. Journal of Nuclear Medicine, 50(2), 198\u2013204. doi: 10.2967\/jnumed.2108.057984 .","journal-title":"Journal of Nuclear Medicine"},{"issue":"10","key":"9067_CR35","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1212\/01.wnl.0000256373.39415.b1","volume":"68","author":"MS Forman","year":"2007","unstructured":"Forman, M. S., Mufson, E. J., Leurgans, S., Pratico, D., Joyce, S., Leight, S., et al. (2007). Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis. Neurology, 68(10), 757\u2013763. doi: 10.1212\/01.wnl.0000256373.39415.b1 .","journal-title":"Neurology"},{"issue":"10","key":"9067_CR36","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","volume":"29","author":"A Forsberg","year":"2008","unstructured":"Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A., et al. (2008). PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiology of Aging, 29(10), 1456\u20131465. doi: 10.1016\/j.neurobiolaging.2007.03.029 .","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"9067_CR37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0197-4580(03)00002-2","volume":"24","author":"RA Frank","year":"2003","unstructured":"Frank, R. A., Galasko, D., Hampel, H., Hardy, J., de Leon, M. J., Mehta, P. D., et al. (2003). Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiology of Aging, 24(4), 521\u2013536. doi: 10.1016\/S0197-4580(03)00002-2 .","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"9067_CR38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410380219","volume":"38","author":"SM Greenberg","year":"1995","unstructured":"Greenberg, S. M., Rebeck, G. W., Vonsattel, J. P., Gomez-Isla, T., & Hyman, B. T. (1995). Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Annals of Neurology, 38(2), 254\u2013259. doi: 10.1002\/ana.410380219 .","journal-title":"Annals of Neurology"},{"issue":"2","key":"9067_CR39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/bbrc.2000.3490","volume":"276","author":"Y Harigaya","year":"2000","unstructured":"Harigaya, Y., Saido, T. C., Eckman, C. B., Prada, C. M., Shoji, M., & Younkin, S. G. (2000). Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Biochemical and Biophysical Research Communications, 276(2), 422\u2013427. doi: 10.1006\/bbrc.2000.3490 .","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"9067_CR40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2463\/mrms.4.27","volume":"4","author":"M Ibaraki","year":"2005","unstructured":"Ibaraki, M., Shimosegawa, E., Toyoshima, H., Ishigame, K., Ito, H., Takahashi, K., et al. (2005). Effect of regional tracer delay on CBF in healthy subjects measured with dynamic susceptibility contrast-enhanced MRI: comparison with 15O-PET. Magnetic Resonance in Medical Sciences, 4(1), 27\u201334. doi: 10.2463\/mrms.4.27 .","journal-title":"Magnetic Resonance in Medical Sciences"},{"issue":"8","key":"9067_CR41","first-page":"1253","volume":"38","author":"M Ichise","year":"1997","unstructured":"Ichise, M., Golan, H., Ballinger, J. R., Vines, D., Blackman, A., & Moldofsky, H. (1997). Regional differences in technetium-99m-ECD clearance on brain SPECT in healthy subjects. Journal of Nuclear Medicine, 38(8), 1253\u20131260.","journal-title":"Journal of Nuclear Medicine"},{"issue":"Pt 6","key":"9067_CR42","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., et al. (2008). Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain, 131(Pt 6), 1630\u20131645. doi: 10.1093\/brain\/awn016 .","journal-title":"Brain"},{"key":"9067_CR43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-7091-3396-5_6","volume-title":"Alzheimer disease: Epidemiology, neuropathology, neurochemistry, and clinics","author":"K Jellinger","year":"1990","unstructured":"Jellinger, K. (1990). Morphology of Alzheimer disease and related disorders. In K. Maurer, P. Riederer & H. Beckmann (Eds.), Alzheimer disease: Epidemiology, neuropathology, neurochemistry, and clinics, pp. 61\u201377. Berlin: Springer-Verlag."},{"key":"9067_CR44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-7091-7508-8_8","volume":"54","author":"KA Jellinger","year":"1998","unstructured":"Jellinger, K. A., & Bancher, C. (1998). Neuropathology of Alzheimer's disease: a critical update. Journal of Neural Transmission. Supplementum, 54, 77\u201395.","journal-title":"Journal of Neural Transmission. Supplementum"},{"issue":"2","key":"9067_CR45","first-page":"309","volume":"135","author":"CL Joachim","year":"1989","unstructured":"Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1989). Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. American Journal of Pathology, 135(2), 309\u2013319.","journal-title":"American Journal of Pathology"},{"issue":"4","key":"9067_CR46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.parkreldis.2007.07.010","volume":"14","author":"A Johansson","year":"2008","unstructured":"Johansson, A., Savitcheva, I., Forsberg, A., Engler, H., Langstrom, B., Nordberg, A., et al. (2008). [(11) C]-PIB imaging in patients with Parkinson's disease: preliminary results. Parkinsonism & Related Disorders, 14(4), 345\u2013347. doi: 10.1016\/j.parkreldis.2007.07.010 .","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"9067_CR47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00019053-200018030-00002","volume":"18","author":"N Johnson","year":"2000","unstructured":"Johnson, N., Davis, T., & Bosanquet, N. (2000). The epidemic of Alzheimer's disease. How can we manage the costs? PharmacoEconomics, 18(3), 215\u2013223. doi: 10.2165\/00019053-200018030-00002 .","journal-title":"PharmacoEconomics"},{"issue":"3","key":"9067_CR48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","volume":"62","author":"KA Johnson","year":"2007","unstructured":"Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., et al. (2007). Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Annals of Neurology, 62(3), 229\u2013234. doi: 10.1002\/ana.21164 .","journal-title":"Annals of Neurology"},{"issue":"19","key":"9067_CR49","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000260969.94695.56","volume":"68","author":"NM Kemppainen","year":"2007","unstructured":"Kemppainen, N. M., Aalto, S., Wilson, I. A., Nagren, K., Helin, S., Bruck, A., et al. (2007). PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology, 68(19), 1603\u20131606. doi: 10.1212\/01.wnl.0000260969.94695.56 .","journal-title":"Neurology"},{"issue":"1","key":"9067_CR50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.21212","volume":"63","author":"NM Kemppainen","year":"2008","unstructured":"Kemppainen, N. M., Aalto, S., Karrasch, M., Nagren, K., Savisto, N., Oikonen, V., et al. (2008). Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Annals of Neurology, 63(1), 112\u2013118. doi: 10.1002\/ana.21212 .","journal-title":"Annals of Neurology"},{"issue":"4","key":"9067_CR51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I","volume":"47","author":"RJ Killiany","year":"2000","unstructured":"Killiany, R. J., Gomez-Isla, T., Moss, M., Kikinis, R., Sandor, T., Jolesz, F., et al. (2000). Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Annals of Neurology, 47(4), 430\u2013439. doi: 10.1002\/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I .","journal-title":"Annals of Neurology"},{"issue":"13","key":"9067_CR52","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0024-3205(01)01232-2","volume":"69","author":"WE Klunk","year":"2001","unstructured":"Klunk, W. E., Wang, Y., Huang, G. F., Debnath, M. L., Holt, D. P., & Mathis, C. A. (2001a). Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sciences, 69(13), 1471\u20131484. doi: 10.1016\/S0024-3205(01)01232-2 .","journal-title":"Life Sciences"},{"issue":"13","key":"9067_CR53","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0024-3205(01)01232-2","volume":"69","author":"WE Klunk","year":"2001","unstructured":"Klunk, W. E., Wang, Y., Huang, G. F., Debnath, M. L., Holt, D. P., & Mathis, C. A. (2001b). Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sciences, 69(13), 1471\u20131484. doi: 10.1016\/S0024-3205(01)01232-2 .","journal-title":"Life Sciences"},{"issue":"9","key":"9067_CR54","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jnen\/61.9.797","volume":"61","author":"WE Klunk","year":"2002","unstructured":"Klunk, W. E., Bacskai, B. J., Mathis, C. A., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., et al. (2002). Imaging A\u00df plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. Journal of Neuropathology and Experimental Neurology, 61(9), 797\u2013805.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"6","key":"9067_CR55","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","volume":"23","author":"WE Klunk","year":"2003","unstructured":"Klunk, W. E., Wang, Y., Huang, G. F., Debnath, M. L., Holt, D. P., Shao, L., et al. (2003a). The binding of 2-(4\u2032-methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component. Journal of Neuroscience, 23(6), 2086\u20132092.","journal-title":"Journal of Neuroscience"},{"issue":"6","key":"9067_CR56","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","volume":"23","author":"WE Klunk","year":"2003","unstructured":"Klunk, W. E., Wang, Y., Huang, G. F., Debnath, M. L., Holt, D. P., Shao, L., et al. (2003b). The binding of 2-(4\u2032-methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component. Journal of Neuroscience, 23(6), 2086\u20132092.","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"9067_CR57","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., et al. (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology, 55(3), 306\u2013319. doi: 10.1002\/ana.20009 .","journal-title":"Annals of Neurology"},{"issue":"46","key":"9067_CR58","doi-asserted-by":"crossref","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","volume":"25","author":"WE Klunk","year":"2005","unstructured":"Klunk, W. E., Lopresti, B. J., Ikonomovic, M. D., Lefterov, I. M., Koldamova, R. P., Abrahamson, E. E., et al. (2005). Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. Journal of Neuroscience, 25(46), 10598\u201310606. doi: 10.1523\/JNEUROSCI.2990-05.2005 .","journal-title":"Journal of Neuroscience"},{"issue":"23","key":"9067_CR59","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","volume":"27","author":"WE Klunk","year":"2007","unstructured":"Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., et al. (2007). Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. Journal of Neuroscience, 27(23), 6174\u20136184. doi: 10.1523\/JNEUROSCI.0730-07.2007 .","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"9067_CR60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13645700600836000","volume":"15","author":"Y Kudo","year":"2006","unstructured":"Kudo, Y. (2006). Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease. Minimally Invasive Therapy & Allied Technologies, 15(4), 209\u2013213. doi: 10.1080\/13645700600836000 .","journal-title":"Minimally Invasive Therapy & Allied Technologies"},{"issue":"4","key":"9067_CR61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2967\/jnumed.106.037556","volume":"48","author":"Y Kudo","year":"2007","unstructured":"Kudo, Y., Okamura, N., Furumoto, S., Tashiro, M., Furukawa, K., Maruyama, M., et al. (2007). 2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy) Benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients. Journal of Nuclear Medicine, 48(4), 553\u2013561. doi: 10.2967\/jnumed.106.037556 .","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"9067_CR62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/JMN:20:1:15","volume":"20","author":"MP Kung","year":"2003","unstructured":"Kung, M. P., Skovronsky, D. M., Hou, C., Zhuang, Z. P., Gur, T. L., Zhang, B., et al. (2003). Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients. Journal of Molecular Neuroscience, 20(1), 15\u201324. doi: 10.1385\/JMN:20:1:15 .","journal-title":"Journal of Molecular Neuroscience"},{"issue":"1\u20132","key":"9067_CR63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2004.08.004","volume":"1025","author":"MP Kung","year":"2004","unstructured":"Kung, M. P., Hou, C., Zhuang, Z. P., Skovronsky, D., & Kung, H. F. (2004). Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease. Brain Research, 1025(1\u20132), 98\u2013105. doi: 10.1016\/j.brainres.2004.08.004 .","journal-title":"Brain Research"},{"issue":"3","key":"9067_CR64","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1021\/bc9901393","volume":"11","author":"A Kurihara","year":"2000","unstructured":"Kurihara, A., & Pardridge, W. M. (2000). Abeta(1\u201340) peptide radiopharmaceuticals for brain amyloid imaging: (111) In chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections. Bioconjugate Chemistry, 11(3), 380\u2013386. doi: 10.1021\/bc9901393 .","journal-title":"Bioconjugate Chemistry"},{"issue":"1","key":"9067_CR65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000109758","volume":"16","author":"LK Kwong","year":"2008","unstructured":"Kwong, L. K., Uryu, K., Trojanowski, J. Q., & Lee, V. M. (2008). TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis. Neuro-Signals, 16(1), 41\u201351. doi: 10.1159\/000109758 .","journal-title":"Neuro-Signals"},{"issue":"6","key":"9067_CR66","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0197-4580(02)00121-5","volume":"23","author":"VM Lee","year":"2002","unstructured":"Lee, V. M. (2002). Related Amyloid binding ligands as Alzheimer's disease therapies. Neurobiology of Aging, 23(6), 1039\u20131042. doi: 10.1016\/S0197-4580(02)00121-5 .","journal-title":"Neurobiology of Aging"},{"issue":"10","key":"9067_CR67","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","volume":"65","author":"V Leinonen","year":"2008","unstructured":"Leinonen, V., Alafuzoff, I., Aalto, S., Suotunen, T., Savolainen, S., Nagren, K., et al. (2008). Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Archives of Neurology, 65(10), 1304\u20131309. doi: 10.1001\/archneur.65.10.noc80013 .","journal-title":"Archives of Neurology"},{"issue":"10","key":"9067_CR68","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1089\/ars.2007.1763","volume":"9","author":"K Leuner","year":"2007","unstructured":"Leuner, K., Hauptmann, S., Abdel-Kader, R., Scherping, I., Keil, U., Strosznajder, J. B., et al. (2007). Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxidants & Redox Signalling, 9(10), 1659\u20131675. doi: 10.1089\/ars.2007.1763 .","journal-title":"Antioxidants & Redox Signalling"},{"key":"9067_CR69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","volume":"309","author":"H LeVine III","year":"1999","unstructured":"LeVine, H,. I. I. I. (1999). Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods in Enzymology, 309, 274\u2013284. doi: 10.1016\/S0076-6879(99)09020-5 .","journal-title":"Methods in Enzymology"},{"key":"9067_CR70","unstructured":"Levine, H., III, & Walker, L. C. (2008). Molecular polymorphism of Abeta in Alzheimer's disease. Neurobiol Aging."},{"key":"9067_CR71","doi-asserted-by":"crossref","unstructured":"Li, Y., Rinne, J. O., Mosconi, L., Pirraglia, E., Rusinek, H., Desanti, S., et al. (2008). \"Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.\" Eur J Nucl Med Mol Imaging.","DOI":"10.1007\/s00259-008-0833-y"},{"issue":"2","key":"9067_CR72","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0197-4580(00)00237-2","volume":"22","author":"CD Link","year":"2001","unstructured":"Link, C. D., Johnson, C. J., Fonte, V., Paupard, M., Hall, D. H., Styren, S., et al. (2001). Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiology of Aging, 22(2), 217\u2013226. doi: 10.1016\/S0197-4580(00)00237-2 .","journal-title":"Neurobiology of Aging"},{"issue":"9","key":"9067_CR73","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1074\/jbc.M412056200","volume":"280","author":"A Lockhart","year":"2005","unstructured":"Lockhart, A., Ye, L., Judd, D. B., Merritt, A. T., Lowe, P. N., Morgenstern, J. L., et al. (2005). Evidence for the presence of three distinct binding sites for the thioflavin T class of Alzheimer's disease PET imaging agents on beta-amyloid peptide fibrils. Journal of Biological Chemistry, 280(9), 7677\u20137684. doi: 10.1074\/jbc.M412056200 .","journal-title":"Journal of Biological Chemistry"},{"issue":"Pt 10","key":"9067_CR74","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/brain\/awm191","volume":"130","author":"A Lockhart","year":"2007","unstructured":"Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., et al. (2007). PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain, 130(Pt 10), 2607\u20132615. doi: 10.1093\/brain\/awm191 .","journal-title":"Brain"},{"key":"9067_CR75","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan, J., Fowler, J. S., Volkow, N. D., Wang, G. J., Ding, Y. S., & Alexoff, D. L. (1996). Distribution volume ratios without blood sampling from graphical analysis of PET data. Journal of Cerebral Blood Flow and Metabolism, 16, 834\u2013840. doi: 10.1097\/00004647-199609000-00008 .","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"12","key":"9067_CR76","first-page":"1959","volume":"46","author":"BJ Lopresti","year":"2005","unstructured":"Lopresti, B. J., Klunk, W. E., Mathis, C. A., Hoge, J. A., Ziolko, S. K., Lu, X., et al. (2005). Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. Journal of Nuclear Medicine, 46(12), 1959\u20131972.","journal-title":"Journal of Nuclear Medicine"},{"issue":"3","key":"9067_CR77","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., et al. (1999). Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. American Journal of Pathology, 155(3), 853\u2013862.","journal-title":"American Journal of Pathology"},{"issue":"41","key":"9067_CR78","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","volume":"27","author":"J Maeda","year":"2007","unstructured":"Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., et al. (2007). Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. Journal of Neuroscience, 27(41), 10957\u201310968. doi: 10.1523\/JNEUROSCI.0673-07.2007 .","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"9067_CR79","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroimage.2007.09.072","volume":"39","author":"W Maetzler","year":"2008","unstructured":"Maetzler, W., Reimold, M., Liepelt, I., Solbach, C., Leyhe, T., Schweitzer, K., et al. (2008). [11C]PIB binding in Parkinson's disease dementia. NeuroImage, 39(3), 1027\u20131033. doi: 10.1016\/j.neuroimage.2007.09.072 .","journal-title":"NeuroImage"},{"issue":"2","key":"9067_CR80","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1471-4159.2007.04972.x","volume":"104","author":"I Maezawa","year":"2008","unstructured":"Maezawa, I., Hong, H. S., Liu, R., Wu, C. Y., Cheng, R. H., Kung, M. P., et al. (2008). Congo red and thioflavin-T analogs detect Abeta oligomers. Journal of Neurochemistry, 104(2), 457\u2013468.","journal-title":"Journal of Neurochemistry"},{"issue":"12","key":"9067_CR81","first-page":"2184","volume":"33","author":"RE Majocha","year":"1992","unstructured":"Majocha, R. E., Reno, J. M., Friedland, R. P., Van Haight, C., Lyle, L. R., & Marotta, C. A. (1992). Development of a monoclonal antibody specific for \u00df\/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy. Journal of Nuclear Medicine, 33(12), 2184\u20132189.","journal-title":"Journal of Nuclear Medicine"},{"issue":"2","key":"9067_CR82","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/bc010066z","volume":"13","author":"JR Marshall","year":"2002","unstructured":"Marshall, J. R., Stimson, E. R., Ghilardi, J. R., Vinters, H. V., Mantyh, P. W., & Maggio, J. E. (2002). Noninvasive imaging of peripherally injected Alzheimer's disease type synthetic A beta amyloid in vivo. Bioconjugate Chemistry, 13(2), 276\u2013284. doi: 10.1021\/bc010066z .","journal-title":"Bioconjugate Chemistry"},{"issue":"8","key":"9067_CR83","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001854","volume":"11","author":"IJ Martins","year":"2006","unstructured":"Martins, I. J., Hone, E., Foster, J. K., Sunram-Lea, S. I., Gnjec, A., Fuller, S. J., et al. (2006). Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Molecular Psychiatry, 11(8), 721\u2013736. doi: 10.1038\/sj.mp.4001854 .","journal-title":"Molecular Psychiatry"},{"issue":"21","key":"9067_CR84","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","volume":"98","author":"E Masliah","year":"2001","unstructured":"Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., et al. (2001). Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America, 98(21), 12245\u201312250. doi: 10.1073\/pnas.211412398 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9067_CR85","unstructured":"Masters, C. L. (2005). Neuropathology of Alzheimer's Disease. Dementia (3rd Edition). A. Burns, J. O'Brien and D. Ames. London, Hodder Arnold: 393-407."},{"key":"9067_CR86","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/CBO9780511544873.030","volume-title":"Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics","author":"CL Masters","year":"2005","unstructured":"Masters, C. L., & Beyreuther, K. (2005). The neuropathology of Alzheimer's disease in the year 2005. In M. F. Beal, A. E. Lang & A. C. Ludolph (Eds.), Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics, pp. 433\u2013440. Cambridge: Cambridge University Press."},{"issue":"Pt 11","key":"9067_CR87","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/brain\/awl251","volume":"129","author":"CL Masters","year":"2006","unstructured":"Masters, C. L., & Beyreuther, K. (2006). Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain, 129(Pt 11), 2823\u20132839. doi: 10.1093\/brain\/awl251 .","journal-title":"Brain"},{"issue":"12","key":"9067_CR88","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences of the United States of America, 82(12), 4245\u20134249. doi: 10.1073\/pnas.82.12.4245 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"9067_CR89","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1471-4159.2006.03989.x","volume":"97","author":"CL Masters","year":"2006","unstructured":"Masters, C. L., Cappai, R., Barnham, K. J., & Villemagne, V. L. (2006). Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. Journal of Neurochemistry, 97(6), 1700\u20131725. doi: 10.1111\/j.1471-4159.2006.03989.x .","journal-title":"Journal of Neurochemistry"},{"issue":"Suppl 1","key":"9067_CR90","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/jlcr.2580440110","volume":"44","author":"CA Mathis","year":"2001","unstructured":"Mathis, C. A., Holt, D. P., Wang, Y., Huang, G. F., Debnath, M. L., & Klunk, W. E. (2001). Lipophilic 11C-labelled thioflavin-T analogues for imaging amyloid plaques in Alzheimer's disease. Journal of Labelled Compounds & Radiopharmaceuticals, 44(Suppl 1), S26\u2013S28.","journal-title":"Journal of Labelled Compounds & Radiopharmaceuticals"},{"issue":"3","key":"9067_CR91","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0960-894X(01)00734-X","volume":"12","author":"CA Mathis","year":"2002","unstructured":"Mathis, C. A., Bacskai, B. J., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Hyman, B. T., et al. (2002a). A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorganic & Medicinal Chemistry Letters, 12(3), 295\u2013298. doi: 10.1016\/S0960-894X(01)00734-X .","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"3","key":"9067_CR92","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0960-894X(01)00734-X","volume":"12","author":"CA Mathis","year":"2002","unstructured":"Mathis, C. A., Bacskai, B. J., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Hyman, B. T., et al. (2002b). A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorganic & Medicinal Chemistry Letters, 12(3), 295\u2013298. doi: 10.1016\/S0960-894X(01)00734-X .","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"13","key":"9067_CR93","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","volume":"46","author":"CA Mathis","year":"2003","unstructured":"Mathis, C. A., Wang, Y., Holt, D. P., Huang, G. F., Debnath, M. L., & Klunk, W. E. (2003). Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. Journal of Medicinal Chemistry, 46(13), 2740\u20132754. doi: 10.1021\/jm030026b .","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"9067_CR94","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archneur.62.2.196","volume":"62","author":"CA Mathis","year":"2005","unstructured":"Mathis, C. A., Klunk, W. E., Price, J. C., & DeKosky, S. T. (2005). Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies. Archives of Neurology, 62(2), 196\u2013200. doi: 10.1001\/archneur.62.2.196 .","journal-title":"Archives of Neurology"},{"issue":"7","key":"9067_CR95","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.nucmedbio.2007.06.015","volume":"34","author":"CA Mathis","year":"2007a","unstructured":"Mathis, C. A., Lopresti, B. J., & Klunk, W. E. (2007a). Impact of amyloid imaging on drug development in Alzheimer's disease. Nuclear Medicine and Biology, 34(7), 809\u2013822. doi: 10.1016\/j.nucmedbio.2007.06.015 .","journal-title":"Nuclear Medicine and Biology"},{"issue":"Suppl. 2","key":"9067_CR96","first-page":"56P","volume":"48","author":"CA Mathis","year":"2007b","unstructured":"Mathis, C. A., Lopresti, B. J., Mason, N., Price, J., Flatt, N., Bi, W., et al. (2007b). Comparison of the amyloid imaging agents [F-18]3\u2019-F-PIB and [C-11]PIB in Alzheimer's disease and control subjects. Journal of Nuclear Medicine, 48(Suppl. 2), 56P.","journal-title":"Journal of Nuclear Medicine"},{"key":"9067_CR97","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 34, 939\u2013944.","journal-title":"Neurology"},{"issue":"6","key":"9067_CR98","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., et al. (1999). Soluble pool of A\u00df amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Annals of Neurology, 46(6), 860\u2013866. doi: 10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M .","journal-title":"Annals of Neurology"},{"issue":"3","key":"9067_CR99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3233\/JAD-2001-3305","volume":"3","author":"CA McLean","year":"2001","unstructured":"McLean, C. A., Beyreuther, K., & Masters, C. L. (2001). Amyloid Abeta levels in Alzheimer's disease - A diagnostic tool and the key to understanding the natural history of Abeta? Journal of Alzheimer's Disease, 3(3), 305\u2013312.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5","key":"9067_CR100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archneur.62.5.721","volume":"62","author":"MS Mega","year":"2005","unstructured":"Mega, M. S., Dinov, I. D., Porter, V., Chow, G., Reback, E., Davoodi, P., et al. (2005). Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study. Archives of Neurology, 62(5), 721\u2013728. doi: 10.1001\/archneur.62.5.721 .","journal-title":"Archives of Neurology"},{"issue":"3","key":"9067_CR101","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/JMN:19:3:289","volume":"19","author":"ML Michaelis","year":"2002","unstructured":"Michaelis, M. L., Dobrowsky, R. T., & Li, G. (2002). Tau neurofibrillary pathology and microtubule stability. Journal of Molecular Neuroscience, 19(3), 289\u2013293. doi: 10.1385\/JMN:19:3:289 .","journal-title":"Journal of Molecular Neuroscience"},{"issue":"3","key":"9067_CR102","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"MA Mintun","year":"2006","unstructured":"Mintun, M. A., Larossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., et al. (2006). [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology, 67(3), 446\u2013452. doi: 10.1212\/01.wnl.0000228230.26044.a4 .","journal-title":"Neurology"},{"issue":"2","key":"9067_CR103","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","volume":"17","author":"JC Morris","year":"2001","unstructured":"Morris, J. C., & Price, A. L. (2001). Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. Journal of Molecular Neuroscience, 17(2), 101\u2013118. doi: 10.1385\/JMN:17:2:101 .","journal-title":"Journal of Molecular Neuroscience"},{"issue":"3","key":"9067_CR104","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","volume":"58","author":"JC Morris","year":"2001","unstructured":"Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., et al. (2001). Mild cognitive impairment represents early-stage Alzheimer disease. Archives of Neurology, 58(3), 397\u2013405. doi: 10.1001\/archneur.58.3.397 .","journal-title":"Archives of Neurology"},{"issue":"Suppl 2","key":"9067_CR105","first-page":"S50","volume":"52","author":"JA Mortimer","year":"1997","unstructured":"Mortimer, J. A. (1997). Brain reserve and the clinical expression of Alzheimer's disease. Geriatrics, 52(Suppl 2), S50\u2013S53.","journal-title":"Geriatrics"},{"issue":"12","key":"9067_CR106","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","volume":"283","author":"J Naslund","year":"2000","unstructured":"Naslund, J., Haroutunian, V., Mohs, R., Davis, K. L., Davies, P., Greengard, P., et al. (2000). Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. Journal of the American Medical Association, 283(12), 1571\u20131577. doi: 10.1001\/jama.283.12.1571 .","journal-title":"Journal of the American Medical Association"},{"issue":"5796","key":"9067_CR107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314(5796), 130\u2013133. doi: 10.1126\/science.1134108 .","journal-title":"Science"},{"issue":"5","key":"9067_CR108","first-page":"748","volume":"47","author":"AB Newberg","year":"2006","unstructured":"Newberg, A. B., Wintering, N. A., Plossl, K., Hochold, J., Stabin, M. G., Watson, M., et al. (2006). Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. Journal of Nuclear Medicine, 47(5), 748\u2013754.","journal-title":"Journal of Nuclear Medicine"},{"issue":"4","key":"9067_CR109","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.106.037762","volume":"48","author":"S Ng","year":"2007a","unstructured":"Ng, S., Villemagne, V. L., Berlangieri, S., Lee, S. T., Cherk, M., Gong, S. J., et al. (2007a). Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease. Journal of Nuclear Medicine, 48(4), 547\u2013552. doi: 10.2967\/jnumed.106.037762 .","journal-title":"Journal of Nuclear Medicine"},{"issue":"8","key":"9067_CR110","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archneur.64.8.1140","volume":"64","author":"SY Ng","year":"2007b","unstructured":"Ng, S. Y., Villemagne, V. L., Masters, C. L., & Rowe, C. C. (2007b). Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B. Archives of Neurology, 64(8), 1140\u20131144. doi: 10.1001\/archneur.64.8.1140 .","journal-title":"Archives of Neurology"},{"issue":"4","key":"9067_CR111","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WCO.0b013e3281a47744","volume":"20","author":"A Nordberg","year":"2007","unstructured":"Nordberg, A. (2007). Amyloid imaging in Alzheimer's disease. Current Opinion in Neurology, 20(4), 398\u2013402. doi: 10.1097\/WCO.0b013e3281a47744 .","journal-title":"Current Opinion in Neurology"},{"issue":"47","key":"9067_CR112","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1523\/JNEUROSCI.1738-05.2005","volume":"25","author":"N Okamura","year":"2005","unstructured":"Okamura, N., Suemoto, T., Furumoto, S., Suzuki, M., Shimadzu, H., Akatsu, H., et al. (2005). Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease. Journal of Neuroscience, 25(47), 10857\u201310862. doi: 10.1523\/JNEUROSCI.1738-05.2005 .","journal-title":"Journal of Neuroscience"},{"issue":"6","key":"9067_CR113","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0969-8051(03)00049-0","volume":"30","author":"M Ono","year":"2003","unstructured":"Ono, M., Wilson, A., Nobrega, J., Westaway, D., Verhoeff, P., Zhuang, Z. P., et al. (2003). 11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease. Nuclear Medicine and Biology, 30(6), 565\u2013571. doi: 10.1016\/S0969-8051(03)00049-0 .","journal-title":"Nuclear Medicine and Biology"},{"issue":"1","key":"9067_CR114","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1474-9726.2006.00196.x","volume":"5","author":"C Opazo","year":"2006","unstructured":"Opazo, C., Luza, S., Villemagne, V. L., Volitakis, I., Rowe, C., Barnham, K. J., et al. (2006). Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease. Aging Cell, 5(1), 69\u201379. doi: 10.1111\/j.1474-9726.2006.00196.x .","journal-title":"Aging Cell"},{"issue":"4","key":"9067_CR115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0733-8619(05)70226-7","volume":"18","author":"RC Petersen","year":"2000","unstructured":"Petersen, R. C. (2000a). Aging, mild cognitive impairment, and Alzheimer's disease. Neurologic Clinics, 18(4), 789\u2013806. doi: 10.1016\/S0733-8619(05)70226-7 .","journal-title":"Neurologic Clinics"},{"issue":"3","key":"9067_CR116","first-page":"93","volume":"15","author":"RC Petersen","year":"2000b","unstructured":"Petersen, R. C. (2000b). Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia (Barcelona, Spain), 15(3), 93\u2013101.","journal-title":"Neurologia (Barcelona, Spain)"},{"issue":"1","key":"9067_CR117","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2006-956752","volume":"27","author":"RC Petersen","year":"2007","unstructured":"Petersen, R. C. (2007). Mild cognitive impairment: current research and clinical implications. Seminars in Neurology, 27(1), 22\u201331. doi: 10.1055\/s-2006-956752 .","journal-title":"Seminars in Neurology"},{"issue":"3","key":"9067_CR118","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56(3), 303\u2013308. doi: 10.1001\/archneur.56.3.303 .","journal-title":"Archives of Neurology"},{"issue":"9","key":"9067_CR119","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","volume":"56","author":"RC Petersen","year":"2001","unstructured":"Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001). Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56(9), 1133\u20131142.","journal-title":"Neurology"},{"issue":"Pt 11","key":"9067_CR120","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","volume":"130","author":"KE Pike","year":"2007","unstructured":"Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., et al. (2007). Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain, 130(Pt 11), 2837\u20132844. doi: 10.1093\/brain\/awm238 .","journal-title":"Brain"},{"issue":"2","key":"9067_CR121","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04591.x","volume":"102","author":"JF Poduslo","year":"2007","unstructured":"Poduslo, J. F., Ramakrishnan, M., Holasek, S. S., Ramirez-Alvarado, M., Kandimalla, K. K., Gilles, E. J., et al. (2007). In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques. Journal of Neurochemistry, 102(2), 420\u2013433. doi: 10.1111\/j.1471-4159.2007.04591.x .","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"9067_CR122","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","volume":"45","author":"JL Price","year":"1999","unstructured":"Price, J. L., & Morris, J. C. (1999). \"Tangles and plaques in nondemented aging and \"preclinical\" Alzheimer's disease. Annals of Neurology, 45(3), 358\u2013368. doi: 10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X .","journal-title":"Annals of Neurology"},{"issue":"11","key":"9067_CR123","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","volume":"25","author":"JC Price","year":"2005","unstructured":"Price, J. C., Klunk, W. E., Lopresti, B. J., Lu, X., Hoge, J. A., Ziolko, S. K., et al. (2005). Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. Journal of Cerebral Blood Flow and Metabolism, 25(11), 1528\u20131547. doi: 10.1038\/sj.jcbfm.9600146 .","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"15","key":"9067_CR124","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/01.wnl.0000259035.98480.ed","volume":"68","author":"GD Rabinovici","year":"2007","unstructured":"Rabinovici, G. D., Furst, A. J., O'Neil, J. P., Racine, C. A., Mormino, E. C., Baker, S. L., et al. (2007). 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology, 68(15), 1205\u20131212. doi: 10.1212\/01.wnl.0000259035.98480.ed .","journal-title":"Neurology"},{"key":"9067_CR125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2007.01.071","volume":"1143","author":"R Resende","year":"2007","unstructured":"Resende, R., Pereira, C., Agostinho, P., Vieira, A. P., Malva, J. O., & Oliveira, C. R. (2007). Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2\u2009+\u2009homeostasis. Brain Research, 1143, 11\u201321. doi: 10.1016\/j.brainres.2007.01.071 .","journal-title":"Brain Research"},{"issue":"9","key":"9067_CR126","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1099-1166(199909)14:9<695::AID-GPS19>3.0.CO;2-R","volume":"14","author":"K Ritchie","year":"1999","unstructured":"Ritchie, K., & Dupuy, A. M. (1999). The current status of apo E4 as a risk factor for Alzheimer's disease: an epidemiological perspective. International Journal of Geriatric Psychiatry, 14(9), 695\u2013700. doi: 10.1002\/(SICI)1099-1166(199909)14:9<695::AID-GPS19>3.0.CO;2-R .","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"3","key":"9067_CR127","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(03)00381-6","volume":"120","author":"S Roder","year":"2003","unstructured":"Roder, S., Danober, L., Pozza, M. F., Lingenhoehl, K., Wiederhold, K. H., & Olpe, H. R. (2003). Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice. Neuroscience, 120(3), 705\u2013720. doi: 10.1016\/S0306-4522(03)00381-6 .","journal-title":"Neuroscience"},{"issue":"11","key":"9067_CR128","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archneur.65.11.1467","volume":"65","author":"CM Roe","year":"2008","unstructured":"Roe, C. M., Mintun, M. A., D'Angelo, G., Xiong, C., Grant, E. A., & Morris, J. C. (2008). Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Archives of Neurology, 65(11), 1467\u20131471. doi: 10.1001\/archneur.65.11.1467 .","journal-title":"Archives of Neurology"},{"issue":"20","key":"9067_CR129","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","volume":"68","author":"CC Rowe","year":"2007","unstructured":"Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., et al. (2007). Imaging beta-amyloid burden in aging and dementia. Neurology, 68(20), 1718\u20131725. doi: 10.1212\/01.wnl.0000261919.22630.ea .","journal-title":"Neurology"},{"issue":"2","key":"9067_CR130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","volume":"7","author":"CC Rowe","year":"2008","unstructured":"Rowe, C. C., Ackerman, U., Browne, W., Mulligan, R., Pike, K. L., O'Keefe, G., et al. (2008). Imaging of amyloid beta in Alzheimer's disease with (18) F-BAY94\u20139172, a novel PET tracer: proof of mechanism. The Lancet Neurology, 7(2), 129\u2013135. doi: 10.1016\/S1474-4422(08)70001-2 .","journal-title":"The Lancet Neurology"},{"issue":"2","key":"9067_CR131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00234-003-1034-9","volume":"46","author":"HI Sair","year":"2004","unstructured":"Sair, H. I., Doraiswamy, P. M., & Petrella, J. R. (2004). In vivo amyloid imaging in Alzheimer's disease. Neuroradiology, 46(2), 93\u2013104. doi: 10.1007\/s00234-003-1034-9 .","journal-title":"Neuroradiology"},{"issue":"41","key":"9067_CR132","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1021\/bi0612667","volume":"45","author":"S Schilling","year":"2006","unstructured":"Schilling, S., Lauber, T., Schaupp, M., Manhart, S., Scheel, E., Bohm, G., et al. (2006). On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry, 45(41), 12393\u201312399. doi: 10.1021\/bi0612667 .","journal-title":"Biochemistry"},{"issue":"8","key":"9067_CR133","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B","volume":"14","author":"J Schneider","year":"1999","unstructured":"Schneider, J., Murray, J., Banerjee, S., & Mann, A. (1999). EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I\u2013Factors associated with carer burden. International Journal of Geriatric Psychiatry, 14(8), 651\u2013661. doi: 10.1002\/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B .","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"8","key":"9067_CR134","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/78422","volume":"18","author":"DJ Selkoe","year":"2000","unstructured":"Selkoe, D. J. (2000). Imaging Alzheimer's amyloid. Nature Biotechnology, 18(8), 823\u2013824. doi: 10.1038\/78422 .","journal-title":"Nature Biotechnology"},{"issue":"5594","key":"9067_CR135","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe, D. J. (2002). Alzheimer's disease is a synaptic failure. Science, 298(5594), 789\u2013791. doi: 10.1126\/science.1074069 .","journal-title":"Science"},{"issue":"4","key":"9067_CR136","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2176","volume":"6","author":"LM Shaw","year":"2007","unstructured":"Shaw, L. M., Korecka, M., Clark, C. M., Lee, V. M., & Trojanowski, J. Q. (2007). Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nature Reviews. Drug Discovery, 6(4), 295\u2013303. doi: 10.1038\/nrd2176 .","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"8","key":"9067_CR137","first-page":"1044","volume":"43","author":"J Shi","year":"2002","unstructured":"Shi, J., Perry, G., Berridge, M. S., Aliev, G., Siedlak, S. L., Smith, M. A., et al. (2002). Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. Journal of Nuclear Medicine, 43(8), 1044\u20131051.","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"9067_CR138","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","volume":"10","author":"K Shoghi-Jadid","year":"2002","unstructured":"Shoghi-Jadid, K., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., et al. (2002a). Localisation of neurofibrillary tangles and \u00df-amyloid plaques in the brains of living patients with Alzheimer's disease. The American Journal of Geriatric Psychiatry, 10(1), 24\u201335.","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"1","key":"9067_CR139","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","volume":"10","author":"K Shoghi-Jadid","year":"2002","unstructured":"Shoghi-Jadid, K., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., et al. (2002b). Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. The American Journal of Geriatric Psychiatry, 10(1), 24\u201335.","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"1\u20132","key":"9067_CR140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/mgme.2001.3236","volume":"74","author":"DH Silverman","year":"2001","unstructured":"Silverman, D. H., & Phelps, M. E. (2001). Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke. Molecular Genetics and Metabolism, 74(1\u20132), 128\u2013138. doi: 10.1006\/mgme.2001.3236 .","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3","key":"9067_CR141","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1385\/JMN:19:3:321","volume":"19","author":"GW Small","year":"2002","unstructured":"Small, G. W., Agdeppa, E. D., Kepe, V., Satyamurthy, N., Huang, S. C., & Barrio, J. R. (2002). In vivo brain imaging of tangle burden in humans. Journal of Molecular Neuroscience, 19(3), 323\u2013327. doi: 10.1385\/JMN:19:3:321 .","journal-title":"Journal of Molecular Neuroscience"},{"issue":"25","key":"9067_CR142","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","volume":"355","author":"GW Small","year":"2006","unstructured":"Small, G. W., Kepe, V., Ercoli, L. M., Siddarth, P., Bookheimer, S. Y., Miller, K. J., et al. (2006). PET of brain amyloid and tau in mild cognitive impairment. New England Journal of Medicine, 355(25), 2652\u20132663. doi: 10.1056\/NEJMoa054625 .","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"9067_CR143","first-page":"19","volume":"62","author":"BJ Small","year":"2007","unstructured":"Small, B. J., Gagnon, E., & Robinson, B. (2007). Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment. Geriatrics, 62(4), 19\u201323.","journal-title":"Geriatrics"},{"issue":"3","key":"9067_CR144","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1017\/S1355617702813248","volume":"8","author":"Y Stern","year":"2002","unstructured":"Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. Journal of the International Neuropsychological Society, 8(3), 448\u2013460. doi: 10.1017\/S1355617702813248 .","journal-title":"Journal of the International Neuropsychological Society"},{"issue":"5","key":"9067_CR145","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., et al. (1993). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 90(5), 1977\u20131981. doi: 10.1073\/pnas.90.5.1977 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"13","key":"9067_CR146","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1523\/JNEUROSCI.4856-03.2004","volume":"24","author":"Z Suo","year":"2004","unstructured":"Suo, Z., Wu, M., Citron, B. A., Wong, G. T., & Festoff, B. W. (2004). Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer's disease: an association with early beta-amyloid accumulation. Journal of Neuroscience, 24(13), 3444\u20133452. doi: 10.1523\/JNEUROSCI.4856-03.2004 .","journal-title":"Journal of Neuroscience"},{"key":"9067_CR147","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal, D. R., Rub, U., Orantes, M., & Braak, H. (2002). Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology, 58, 1791\u20131800.","journal-title":"Neurology"},{"key":"9067_CR148","unstructured":"Thal, D. R., Del Tredici, K., & Braak, H. (2004). \"Neurodegeneration in normal brain aging and disease.\" Sci Aging Knowledge Environ 2004(23): pe26."},{"issue":"Suppl. 2","key":"9067_CR149","doi-asserted-by":"crossref","first-page":"T100","DOI":"10.1016\/j.neuroimage.2006.04.087","volume":"21","author":"N Tolboom","year":"2006","unstructured":"Tolboom, N., Yaqub, M., Lubberink, M., Kloet, R. W., Boellaard, R., Windhorst, B., et al. (2006). Test\u2013retest variability of [11C]PIB studies in healthy subjects and AD patients. NeuroImage, 21(Suppl. 2), T100. doi: 10.1016\/j.neuroimage.2006.04.087 .","journal-title":"NeuroImage"},{"issue":"3","key":"9067_CR150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.21321","volume":"63","author":"T Tomiyama","year":"2008","unstructured":"Tomiyama, T., Nagata, T., Shimada, H., Teraoka, R., Fukushima, A., Kanemitsu, H., et al. (2008). A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Annals of Neurology, 63(3), 377\u2013387. doi: 10.1002\/ana.21321 .","journal-title":"Annals of Neurology"},{"issue":"5","key":"9067_CR151","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00259-005-1780-5","volume":"32","author":"H Toyama","year":"2005","unstructured":"Toyama, H., Ye, D., Ichise, M., Liow, J. S., Cai, L., Jacobowitz, D., et al. (2005). PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imaging, 32(5), 593\u2013600.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"9067_CR152","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0197-4580(02)00123-9","volume":"23","author":"JQ Trojanowski","year":"2002","unstructured":"Trojanowski, J. Q. (2002). \"\"Emerging Alzheimer's disease therapies: focusing on the future. Neurobiology of Aging, 23(6), 985\u2013990.","journal-title":"Neurobiology of Aging"},{"issue":"6","key":"9067_CR153","first-page":"584","volume":"12","author":"NP Verhoeff","year":"2004","unstructured":"Verhoeff, N. P., Wilson, A. A., Takeshita, S., Trop, L., Hussey, D., Singh, K., et al. (2004). In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. The American Journal of Geriatric Psychiatry, 12(6), 584\u2013595.","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"3","key":"9067_CR154","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jocn.2004.03.011","volume":"12","author":"VL Villemagne","year":"2005","unstructured":"Villemagne, V. L., Rowe, C. C., Macfarlane, S., Novakovic, K. E., & Masters, C. L. (2005). Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease. Journal of Clinical Neuroscience, 12(3), 221\u2013230. doi: 10.1016\/j.jocn.2004.03.011 .","journal-title":"Journal of Clinical Neuroscience"},{"key":"9067_CR155","first-page":"5","volume-title":"Abeta Peptide and Alzheimer\u2019s Disease","author":"VL Villemagne","year":"2006a","unstructured":"Villemagne, V. L., Cappai, R., Barnham, K. J., Cherny, R., Opazo, C., Novakovic, K. E., et al. (2006a). The Abeta centric pathway of Alzheimer\u2019s disease. In C. J. Barrow & B. J. Small (Eds.), Abeta Peptide and Alzheimer\u2019s Disease, pp. 5\u201332. London: Springer-Verlag."},{"key":"9067_CR156","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/197140090601900406","volume":"19","author":"VL Villemagne","year":"2006b","unstructured":"Villemagne, V. L., Ng, S., Cappai, R., Barnham, K. J., Fodero-Tavoletti, M. T., Rowe, C. C., et al. (2006b). La Lunga Attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer\u2019s disease. The Neuroradiology Journal, 19, 51\u201375.","journal-title":"The Neuroradiology Journal"},{"key":"9067_CR157","doi-asserted-by":"crossref","first-page":"216P","DOI":"10.2967\/jnumed.107.045484","volume":"49","author":"VL Villemagne","year":"2008a","unstructured":"Villemagne, V. L., Ataka, S., Brooks, W., Wada, Y., Jones, G., Watanabe, Y., et al. (2008a). Pattern of Abeta deposition in familial Alzheimer's disease is irrespective of mutation type or cognitive status. Journal of Nuclear Medicine, 49, 216P. doi: 10.2967\/jnumed.107.045484 . abstract.","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"9067_CR158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-008-8019-y","volume":"38","author":"VL Villemagne","year":"2008b","unstructured":"Villemagne, V. L., Fodero-Tavoletti, M. T., Pike, K. E., Cappai, R., Masters, C. L., & Rowe, C. C. (2008b). The ART of Loss: abeta imaging in the evaluation of Alzheimer's disease and other dementias. Molecular Neurobiology, 38(1), 1\u201315. doi: 10.1007\/s12035-008-8019-y .","journal-title":"Molecular Neurobiology"},{"key":"9067_CR159","first-page":"35P","volume":"49","author":"VL Villemagne","year":"2008c","unstructured":"Villemagne, V. L., Pike, K. E., Ackermann, U., Jones, G., Ames, D., Ellis, K., et al. (2008c). A longitudinal study of beta-amyloid deposition with 11C-PIB-PET. Journal of Nuclear Medicine, 49, 35P. abstract.","journal-title":"Journal of Nuclear Medicine"},{"issue":"6","key":"9067_CR160","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.neuropsychologia.2008.02.008","volume":"46","author":"VL Villemagne","year":"2008d","unstructured":"Villemagne, V. L., Pike, K. E., Darby, D., Maruff, P., Savage, G., Ng, S., et al. (2008d). Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia, 46(6), 1688\u20131697. doi: 10.1016\/j.neuropsychologia.2008.02.008 .","journal-title":"Neuropsychologia"},{"key":"9067_CR161","first-page":"34P","volume":"49","author":"VL Villemagne","year":"2008e","unstructured":"Villemagne, V. L., Pike, K. E., Fodero-Tavoletti, M. T., Jones, G., McLean, C., Hinton, F., et al. (2008e). Age dependent prevalence of beta-amyloid positive 11C-PIB PET in healthy elderly subjects parallels neuropathology findings. Journal of Nuclear Medicine, 49, 34P. abstract.","journal-title":"Journal of Nuclear Medicine"},{"issue":"4","key":"9067_CR162","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005072-199407000-00009","volume":"53","author":"LC Walker","year":"1994","unstructured":"Walker, L. C., Price, D. L., Voytko, M. L., & Schenk, D. B. (1994). Labelling of cerebral amyloid in vivo with a monoclonal antibody. Journal of Neuropathology and Experimental Neurology, 53(4), 377\u2013383. doi: 10.1097\/00005072-199407000-00009 .","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"1","key":"9067_CR163","first-page":"5","volume":"49","author":"LC Walker","year":"2008","unstructured":"Walker, L. C., Rosen, R. F., & Levine, H,. I. I. I. (2008). Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity? Romanian Journal of Morphology and Embryology, 49(1), 5\u201311.","journal-title":"Romanian Journal of Morphology and Embryology"},{"issue":"6880","key":"9067_CR164","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., et al. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416(6880), 535\u2013539. doi: 10.1038\/416535a .","journal-title":"Nature"},{"issue":"Pt 5","key":"9067_CR165","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1042\/BST0331087","volume":"33","author":"DM Walsh","year":"2005","unstructured":"Walsh, D. M., Klyubin, I., Shankar, G. M., Townsend, M., Fadeeva, J. V., Betts, V., et al. (2005). The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. Biochemical Society Transactions, 33(Pt 5), 1087\u20131090. doi: 10.1042\/BST20051087 .","journal-title":"Biochemical Society Transactions"},{"issue":"2","key":"9067_CR166","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","volume":"158","author":"J Wang","year":"1999","unstructured":"Wang, J., Dickson, D. W., Trojanowski, J. Q., & Lee, V. M. (1999). The levels of soluble versus insoluble brain A\u00df distinguish Alzheimer's disease from normal and pathologic aging. Experimental Neurology, 158(2), 328\u2013337. doi: 10.1006\/exnr.1999.7085 .","journal-title":"Experimental Neurology"},{"issue":"Suppl 1","key":"9067_CR167","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/s00259-007-0698-5","volume":"35","author":"M Wermke","year":"2008","unstructured":"Wermke, M., Sorg, C., Wohlschlager, A. M., & Drzezga, A. (2008). A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging, 35(Suppl 1), S12\u2013S24. doi: 10.1007\/s00259-007-0698-5 .","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"1","key":"9067_CR168","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.410410122","volume":"41","author":"S Whyte","year":"1997","unstructured":"Whyte, S., Wilson, N., Currie, J., Maruff, P., Malone, V., Shafiq-Antonacci, R., et al. (1997). Collection and normal levels of the amyloid precursor protein in plasma. Annals of Neurology, 41(1), 121\u2013124. doi: 10.1002\/ana.410410122 .","journal-title":"Annals of Neurology"},{"key":"9067_CR169","first-page":"214P","volume":"49","author":"DF Wong","year":"2008","unstructured":"Wong, D. F., Rosenberg, P., Zhou, Y., Kumar, A., Ravert, H., Brasic, J., et al. (2008). In vivo imaging of amyloid deposition in Alzheimer's disease using the novel radioligand [F-18]AV-45. Journal of Nuclear Medicine, 49, 214P. doi: 10.2967\/jnumed.108.052597 . abstract.","journal-title":"Journal of Nuclear Medicine"},{"issue":"9","key":"9067_CR170","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.54.9.1760","volume":"54","author":"Y Xu","year":"2000","unstructured":"Xu, Y., Jack, C. R,. Jr, O'Brien, P. C., Kokmen, E., Smith, G. E., Ivnik, R. J., et al. (2000). Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology, 54(9), 1760\u20131767.","journal-title":"Neurology"},{"issue":"25","key":"9067_CR171","doi-asserted-by":"crossref","first-page":"23599","DOI":"10.1074\/jbc.M501285200","volume":"280","author":"L Ye","year":"2005","unstructured":"Ye, L., Morgenstern, J. L., Gee, A. D., Hong, G., Brown, J., & Lockhart, A. (2005). Delineation of positron emission tomography imaging agent binding sites on beta-amyloid peptide fibrils. Journal of Biological Chemistry, 280(25), 23599\u201323604. doi: 10.1074\/jbc.M501285200 .","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"9067_CR172","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1471-4159.2008.05245.x","volume":"105","author":"L Ye","year":"2008","unstructured":"Ye, L., Velasco, A., Fraser, G., Beach, T. G., Sue, L., Osredkar, T., et al. (2008). In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain. Journal of Neurochemistry, 105(4), 1428\u20131437. doi: 10.1111\/j.1471-4159.2008.05245.x .","journal-title":"Journal of Neurochemistry"},{"key":"9067_CR173","first-page":"404P","volume":"48","author":"S Yee","year":"2007","unstructured":"Yee, S., Mathis, C., Klunk, W., Weissfeld, L., Lopresti, B., Bi, W., et al. (2007). Optimal time window for standardized uptake ratio as a simplified measure of PIB retension. Journal of Nuclear Medicine, 48, 404P.","journal-title":"Journal of Nuclear Medicine"},{"issue":"8","key":"9067_CR174","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S1474-4422(06)70503-8","volume":"5","author":"H Zetterberg","year":"2006","unstructured":"Zetterberg, H., & Blennow, K. (2006). Plasma Abeta in Alzheimer's disease\u2013up or down? The Lancet Neurology, 5(8), 638\u2013639. doi: 10.1016\/S1474-4422(06)70503-8 .","journal-title":"The Lancet Neurology"},{"issue":"8","key":"9067_CR175","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.nucmedbio.2005.06.001","volume":"32","author":"W Zhang","year":"2005","unstructured":"Zhang, W., Oya, S., Kung, M. P., Hou, C., Maier, D. L., & Kung, H. F. (2005). F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. Nuclear Medicine and Biology, 32(8), 799\u2013809. doi: 10.1016\/j.nucmedbio.2005.06.001 .","journal-title":"Nuclear Medicine and Biology"}],"container-title":["Brain Imaging and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11682-009-9067-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11682-009-9067-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11682-009-9067-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T11:25:09Z","timestamp":1710242709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11682-009-9067-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,7]]},"references-count":175,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["9067"],"URL":"https:\/\/doi.org\/10.1007\/s11682-009-9067-2","relation":{},"ISSN":["1931-7557","1931-7565"],"issn-type":[{"value":"1931-7557","type":"print"},{"value":"1931-7565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,7]]}}}